Skip to main content
$0.125 (0%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
If you were already registered, log in here.

Short Interest

ASIC data, 13 May 2026

% Shorted

0.00%
vs 0.00% prior report

Most Shorted Rank

661st
of 717 shorted ASX stocks

Peak Short

0.63%
Nov 2024

Days to Cover

0.0
at 50d avg vol
Subject
CYP Ann: Cynata to Present at MST Access Investor Conference 15 June

CYP Ann: Cynata signs Licence Agreement with TekCyte

CYP Ann: Release of Securities from Voluntary Escrow

CYP Ann: First Patient Enrolled in Cynata MEND Clinical Trial

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Expands trial in COVID-19 & Respiratory Failure

CYP Ann: Cynata Investor Presentation

CYP Ann: New Study to Investigate the High Potency of Cymerus MSCs

CYP Ann: Cynata Advances Planned Clinical Trial in DFU with TekCyte

CYP Ann: Appendix 4D & Half-Year Financial Statements

CYP Ann: Cynata Receives $1.39m R&D Tax Incentive Refund

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cleansing Notice

CYP Ann: Appendix 2A

CYP Ann: Completion of Entitlement Offer and Shortfall Placement

CYP Ann: Entitlement Offer Closing Date Reminder

CYP Ann: Cleansing Notice

CYP Ann: Appendix 2A

CYP Ann: 2020 Review and Outlook

CYP Ann: Becoming a substantial holder

CYP Ann: Cleansing Notice

CYP Ann: Appendix 2A

CYP Ann: Letter to Ineligible Shareholders

CYP Ann: Offer Booklet and Entitlement & Acceptance Form

CYP Ann: Cynata Entitlement Offer Opens

CYP Ann: Cleansing Notice

CYP Ann: Cynata provides update on Placement and Appendix 2A

CYP Ann: Letter to Optionholders

CYP Ann: Notice Under Section 708AA of the Corporations Act

CYP Ann: Investor Presentation

CYP Ann: Proposed issue of Securities - CYP

CYP Ann: CYP Closes $15m Institutional Placement to Expand Pipeline

CYP Ann: Trading Halt

CYP Ann: Appendix 3Ys x 5

CYP Ann: Appendix 3G

CYP Ann: Replacement Constitution

CYP Ann: Results of Annual General Meeting

CYP Ann: AGM Presentations

CYP Ann: Cynata Technology Featured on Front Cover of Nature Medicine

CYP Ann: Phase 3 Osteoarthritis Clinical Trial Commences

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: AusBiotech Conference Presentation

CYP Ann: Annual Report to Shareholders

CYP Ann: Letter to Shareholders, Notice of AGM & Proxy Form

CYP Article: 'It had the smell of Lehman Brothers'

CYP Article: Alium ups stake in Emerald Clinics in upcoming IPO

CYP Article: The interview questions these 28 Australian CEOs always ask ...

CYP Article: Markets Live: Financials plummet on euro concerns

If you were already registered, log in here.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS